China Resources Medical Holdings Co (FRA:1PH) EBIT: €94 Mil (TTM As of Dec. 2025)


FRA:1PH China Resources Medical Holdings Co Ltd FRA:1PH
54 GF Score
Price €0.26
GF Value €0.43
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is China Resources Medical Holdings Co EBIT?

China Resources Medical Holdings Co FRA:1PH -0.75% 54 EBIT is €94 Mil as of Dec. 2025. GuruFocus rates FRA:1PH with a GF Score™ of 54/100 and a GF Value™ of €0.43 (Possible Value Trap). The stock has 5 warning signs investors should review.

China Resources Medical Holdings Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €30 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €94 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Resources Medical Holdings Co's annualized ROC % for the quarter that ended in Dec. 2025 was 2.95%. China Resources Medical Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 9.28%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Resources Medical Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 19.15%.

China Resources Medical Holdings Co  (FRA:1PH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Resources Medical Holdings Co's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=51.272 * ( 1 - 24.08% )/( (1325.897 + 1316.354)/ 2 )
=38.9257024/1321.1255
=2.95 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1640.402 - 460.624 - ( 150.285 - max(0, 570.478 - 424.359+150.285))
=1325.897

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1565.902 - 440.802 - ( 113.931 - max(0, 537.137 - 345.883+113.931))
=1316.354

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

China Resources Medical Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=59.212/( ( (629.12 + max(-187.479, 0)) + (646.831 + max(-253.904, 0)) )/ 2 )
=59.212/( ( 629.12 + 646.831 )/ 2 )
=59.212/637.9755
=9.28 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(194.488 + 36.299 + 42.358) - (460.624 + 0 + -1.1368683772162E-13)
=-187.479

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(150.703 + 31.783 + 14.931) - (440.802 + 0 + 10.519)
=-253.904

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Resources Medical Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=94.259/492.303
=19.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Medical Holdings Co EBIT Related Terms

China Resources Medical Holdings Co EBIT Historical Data

* Premium members only.

The historical data trend for China Resources Medical Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Medical Holdings Co EBIT Chart

China Resources Medical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.84 64.84 78.06 118.01 94.53

China Resources Medical Holdings Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.08 85.43 30.50 64.65 29.61

FRA:1PH vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Resources Medical Holdings Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Resources Medical Holdings Co's EV-to-EBIT falls into.


FRA:1PH
54GF Score
China Resources Medical Holdings Co Ltd FRA:1PH
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Medical Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €94 Mil mean?
China Resources Medical Holdings Co (FRA:1PH) has a EBIT of €94 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on China Resources Medical Holdings Co.
Is China Resources Medical Holdings Co's EBIT too high?
China Resources Medical Holdings Co's current EBIT is €94 Mil. Overall, China Resources Medical Holdings Co has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's EBIT compare to HCA and THC?
China Resources Medical Holdings Co's EBIT of €94 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on China Resources Medical Holdings Co. China Resources Medical Holdings Co's current EBIT is €94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, China Resources Medical Holdings Co (FRA:1PH) is currently considered Possible Value Trap. The stock's GF Value™ is €0.43, compared to a current price of €0.26 — trading 38.6% below its estimated fair value. The current EBIT is €94 Mil. China Resources Medical Holdings Co's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For China Resources Medical Holdings Co (FRA:1PH), the current EBIT is €94 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Medical Holdings Co (FRA:1PH) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued. The current stock price of €0.26 is trading 38.6% below its estimated GF Value™ of €0.43. GuruFocus considers China Resources Medical Holdings Co to be Possible Value Trap.

Key valuation signals for FRA:1PH:

  • EBIT: €94 Mil
  • GF Value™: €0.43 vs. price of €0.26 (38.6% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the FRA:1PH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Medical Holdings Co Business Description

Other Exchanges 01515:Hong Kong
Address No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
54GF Score

Get the complete analysis for FRA:1PH

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.43
GF Value